Home
Search
381 Results Found

Gavel sitting on top of a book that reads PATENT LAW
#TBT: Debunking Some Common Myths on Patent Protections
The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine the U.S. patent system this morning. Ahead of the hearing – and in honor of #ThrowBackThursay – we are resurfacing a piece by BIO’s Tom DiLenge that helps debunk some of the most…

BTN-MTC_Patient-Pharmacy.png
How Can We Control Drug Costs While Supporting Innovation?
As the debate on drug pricing continues, our elected leaders will almost certainly adopt policies that will significantly impact—for better or for worse—the lives of many patients. With that in mind, how we do we ensure patients are at the center of this discussion? It starts by recognizing some…

Gavel sitting on top of a book that reads PATENT LAW
BIO’s Hans Sauer Calls for Less Confusing Patent Eligibility Standards
Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of three hearings in the Intellectual Property Subcommittee of the Senate Judiciary Committee on the subject of “The State of Patent Eligibility in America.” The hearings are looking at Section 101…

Gavel sitting on top of a book that reads PATENT LAW
Licensing of Research Has Had Huge Impact on Economy & Jobs
A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately comes from public funding of early-stage basic research. The licensing of this research has significantly expanded US gross domestic product, industrial gross output, and jobs over the last 22 years.  …

Hands putting a drop of liquid substance into a tube
Setting the Record Straight on March-In Rights
In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government has the power to effectively impose price controls over products that have a link to federally-funded research through its patent “march-in” rights under the Bayh-Dole…

Gavel sitting on top of a book that reads PATENT LAW
When Intervention Stifles Innovation
Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore School of Law shared his objections to legislative proposals that falsely link drug costs with patents in an op-ed that ran in The Washington Times this week. As Dolin states, current legislative proposals would…

Photo of Senator Birch Bayh
Happy 91st Birthday Senator Bayh!
At its best, government enables citizens to flourish socially and economically. Above and beyond the basic services we all expect, responsible governments empower citizens to provide for themselves in a rapidly evolving world. Through Senator Birch Bayh’s long career of public service, he led a…

USMCA Paves the Way for Biotech Innovation
After more than a year of high-stakes drama, the U.S. has inked an updated trade agreement with Mexico and Canada. The U.S.-Mexico-Canada Trade Agreement, otherwise known as the USMCA, has achieved an important step in bringing our neighboring countries closer to high U.S. intellectual property…